July 17 Test

The chart shows the growth of an initial investment of $10,000 in July 17 Test, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Oct 1, 2020, July 17 Test's average daily return is +0.17%, while the average monthly return is +3.50%. At this rate, your investment would double in approximately 1.7 years.

Historically, 69% of months were positive and 31% were negative. The best month was Nov 2020 with a return of +29.4%, while the worst month was Apr 2022 at -8.5%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 3 months.

On a daily basis, July 17 Test closed higher 55% of trading days. The best single day was Apr 9, 2025 with a return of +9.8%, while the worst single day was Apr 4, 2025 at -6.3%.

July 17 Test has an annualized alpha of 32.36%, beta of 1.03, and R² of 0.58 versus S&P 500 Index. Calculated based on daily prices since October 01, 2020.

• This portfolio captured 165.97% of S&P 500 Index gains but only 21.23% of its losses — a favorable profile for investors.
• This portfolio generated an annualized alpha of 32.36% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.
• With beta of 1.03 and R² of 0.58, this portfolio moves broadly in line with S&P 500 Index — much of its variation is explained by market exposure rather than independent behavior.

July 17 Test has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

July 17 Test ranks 97 for risk / return — in the top 97% of portfolios on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

July 17 Test Sharpe ratios as of Apr 3, 2026 (values are recalculated daily):

• 1-Year: 2.96
• 5-Year: 1.83
• All Time: 2.12

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 0.98 to 1.67, this portfolio's current Sharpe ratio is in the top 25%. This signifies superior risk-adjusted performance, meaning the portfolio is delivering strong returns for the level of risk taken compared to most others.

The chart below shows the rolling Sharpe ratio of July 17 Test compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

July 17 Test provided a 0.72% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the July 17 Test. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the July 17 Test was 23.29%, occurring on Jun 16, 2022. Recovery took 231 trading sessions.

The current July 17 Test drawdown is 0.32%.

The chart below shows the rolling one-month volatility.